Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Share your knowledge and expertise with your regulatory peers by submitting an in-depth, evidence-based article focusing on key areas and emerging issues in the global regulatory landscape.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
RAPS Euro Convergence brings regulatory peers from the EU and worldwide together in one forum to gain insights and exchange ideas on the region's most pressing issues. Register today to attend 10-12 May 2021.
Registration is now open for RAPS Convergence 2021! Gather with the regulatory community 12-15 September for four days of learning, engagement, and excitement.
With contributions from more than 30 authors from seven countries, the new edition incorporates a global overview of the field and is designed to help you get the most out of your regulatory intelligence endeavors.
Regipedia is an interactive resource created to benefit RAPS members with 24/7 access to more than 2,300 regulatory terms.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 26 March 2012 | By Alexander Gaffney, RAC
A unanimous decision last week by the Supreme Court of the United States (SCOTUS) against the US Environmental Protection Agency (EPA) could place warnings letters sent by the US Food and Drug Administration (FDA) into a quagmire of litigation, report various sources.
In Sackett v. EPA, SCOTUS ruled the Administrative Procedure Act-the act governing how FDA and other federal agencies create regulations and make decisions-did not preclude the litigants from immediately challenging EPA compliance orders.
While the ruling rejected Sackett's arguments that the orders-similar to FDA warning letters-violated Sackett's due process rights under the constitution, the ruling could mire future warning letters in a sea of litigation, writes Nina Mendelson of the Center for Progressive Reform.
"[EPA] may use compliance orders less often and when it does use them, it may take much longer for the orders to go into effect," concludes Mendelson.
Read more:
Center for Progressive Reform - SCOTUS Decision in Sackett v. EPA Weakens Government's Ability to Respond to Urgent Threats to Water Quality
The Pink Sheet Daily - FDA Warning Letters Could Face Litigation In Wake Of Supreme Court's EPA Ruling
Center for Progressive Reform - After Sackett: What Next for Administrative Compliance Orders?
Penn Program on Regulation - Opinion: Rule of Law Prevails in Sackett v. EPA
Tags: Administrative Procedure Act, Sackett v. EPA, EPA, Justice, warning letter, SCOTUS, Law, Latest News, decision, warning letters
Regulatory Focus newsletters
All the biggest regulatory news and happenings.